Michael S. Kim, MD

University of California, Los Angeles; Los Angeles, CA
Clinical Instructor, Clinical Fellow of Brachytherapy
Department of Radiation Oncology

Dalhousie University; Halifax, NS, Canada
Resident Physician
Chief Resident
Nova Scotia Cancer Center

University of Western Ontario; London, ON, Canada
Doctor of Medicine

McMaster University; Hamilton, ON, Canada
Bachelor of Sciences with Honors, Biochemistry
Summa cum laude

Dr. Michael S. Kim is an Assistant Professor in the Department of Radiation Oncology at the University of Maryland. His primary areas of clinical and research interest include genitourinary, gastrointestinal, and musculoskeletal malignancies.

Dr. Kim completed most of his education and training in Canada, studying Biochemistry at McMaster University then subsequently graduated from University of Western Ontario with his Medical Doctorate.

He completed his residency training in Halifax at the Nova Scotia Cancer Center, serving as Chief Resident. During his training, he was involved in national efforts in postgraduate education through the Canadian Association of Radiation Oncology and the Canadian Radiation Oncology Foundation.

Dr. Kim underwent further training with a Brachytherapy fellowship at the University of California, Los Angeles under Dr. Albert Chang. His fellowship consisted of performing brachytherapy procedures across the entire body, focusing primarily on Prostate and Gynecological cancers, but included metastases-directed therapy to pelvis, lung, skin, and the head and neck.

Prostate cancer, Gastrointestinal cancers, Sarcoma, brachytherapy, medical education, radioembolization,

1. Malik NH, Kim MS, Chen H, Poon I, Husain Z, Eskander A, Boldt G, Louie AV, Karam I. Stereotactic Radiation Therapy for De Novo Head and Neck Cancers: A Systematic Review and Meta-Analysis. Adv Radiat Oncol. 2020 Nov 28;6(1):100628.
2. Kim MS, Malik NH, Chen H, Poon I, Husain Z, Eskander A, Boldt G, Louis AV, Karem I. Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review. Head Neck. 2022 Mar;44(3):770–82. 
3. Kim MS, Sheridan M, Rajaraman M, Hollenhorst H, Caissie A, Mahmoud-Ahmed A, Lamond N, Snow S, Corsten M, Taylor SM, Trites JRB, Rigby MH, Bullock M, Wilke D. The impact of national holidays on postoperative radiotherapy of squamous cell carcinoma of the head and neck. Clin Transl Radiat Oncol. 2023